Ascentage Pharma Announces Global Registrational Phase III Study of Lisaftoclax for First-line Treatment of Patients with Higher-Risk Myelodysplastic Syndrome Cleared by US FDA and EMA
ROCKVILLE, Md. and SUZHOU, China, Aug. 17, 2025 (GLOBE NEWSWIRE) -- Ascentage…
Novartis announces both ianalumab Phase III clinical trials met primary endpoint in patients with Sjgrens disease
Ad hoc announcement pursuant to Art. 53 LR NEPTUNUS-1 and NEPTUNUS-2 are…
Roche to advance prasinezumab into Phase III development for early-stage Parkinson’s disease
Results from Phase IIb PADOVA and longer term follow-up data suggest clinical…
Accomplished Biotech Executive Frederick Beddingfield III, M.D., Ph.D. Joins Neurodons Board of Directors
CROWN POINT, Ind., June 11, 2025 (GLOBE NEWSWIRE) -- Neurodon Corp., a…
Hyundai Motor Group Opens ZER01NE Fund III to Drive Future Technology Innovation with Startups
ZER01NE Fund III, valued at KRW 125 billion, aims to accelerate innovation…
Energize Capital raises $430 million to capitalize and scale digitally-enabled climate solutions
Backed by leading institutional Limited Partners, Ventures Fund III underscores the need…
